PMID: 6963163Nov 1, 1982Paper

Vulvovaginal candidiasis: treatment and recurrence

The Australian & New Zealand Journal of Obstetrics & Gynaecology
G J Dennerstein, R Langley

Abstract

This study compares the effectiveness of 6 treatment regimens for vulvovaginal candidiasis with 6 months' follow-up. 292 patients randomly allocated to the treatments completed the trial. Significant differences were found in the rates of recurrence within the different treatment groups. The most successful treatment was miconazole vaginal cream with oral nystatin, with a cure rate of 81%. The high rate of recurrence of this condition is noted and the need for at least 6 months' follow-up in future trials of candidacides is emphasized.

References

Oct 24, 1977·JAMA : the Journal of the American Medical Association·M R MilesA Rogers
Jul 1, 1979·British Journal of Obstetrics and Gynaecology·B W EliotA E Mack
May 16, 1970·The Medical Journal of Australia·G J Dennerstein

❮ Previous
Next ❯

Citations

Aug 1, 1985·American Journal of Obstetrics and Gynecology·J D Sobel
May 12, 2006·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Jirí SpacekMiroslav Förstl
Sep 1, 1989·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·H T SalemM H Makarem

❮ Previous
Next ❯

Related Concepts

Related Feeds

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Related Papers

Archives of Dermatology
N CrutcherS M Baker
Acta Obstetricia Et Gynecologica Scandinavica
V K Hopsu-HavuR Punnonen
Oral Surgery, Oral Medicine, and Oral Pathology
S R Porter, C Scully
© 2021 Meta ULC. All rights reserved